RegisterLogin

UVI 3003

CAT: 0804-HY-107500-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-107500-01Size:5 mg
Selected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
UVI 3003 is a highly selective antagonist of retinoid X receptor (RXR), and inhibits xenopus and human RXRα in Cos7 cells, with IC50s of 0.22 and 0.24 μM, respectively.
CAS Number
[847239-17-2]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; RAR/RXR
Type
Reference compound
Related Pathways
Autophagy; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/UVI_3003.html
Purity
99.57
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCCCOC1=C(C2=CC(/C=C/C(O)=O)=CC=C2O)C=C3C(C(C)(CCC3(C)C)C)=C1
Molecular Formula
C28H36O4
Molecular Weight
436.58
Precautions
H302, H315, H319, H335
References & Citations
[1]Zhu J, et al. The unexpected teratogenicity of RXR antagonist UVI3003 via activation of PPARγ in Xenopus tropicalis. Toxicol Appl Pharmacol. 2017 Jan 1;314:91-97.|[2]Hebert SL, et al. Effects of retinoic acid signaling on extraocular muscle myogenic precursor cells in vitro. Exp Cell Res. 2017 Dec 1;361 (1) :101-111.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-118798-01DA 3003-2
HY-124766ABD-3001
HY-N11097FK-3000
HY-129207-01JMV 3002
HY-111249TTT 3002
HY-105450GPI-3000
HY-159919UM-3006
HY-129287JMV 3008
HY-P4056CIGB-300
HY-103428LE 300

Alternative Products

CatalogName
BISN0065-01UVI 3003
C08896-01UVI 3003
B7353-10UVI 3003
MBS3614451-01UVI 3003
BUP05258-01UVI 3003
B7353-50UVI 3003
B7353-5UVI 3003
MBS3844461-01UVI 3003
257033-01UVI 3003
MBS5764702UVI 3003

Popular Products